I was talking about Azer-Cel. IMU didn't see the efficacy early for Cohort A so combined it with IL-2 for Cohort B, possibly why Novartis didn't show interest in advancement with Precision and also purchase of the manufacturing plant requirement.
I was talking about Azer-Cel. IMU didn't see the efficacy early...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
-0.015(5.36%) |
Mkt cap ! $76.45M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 26.5¢ | $328.1K | 1.211M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 596675 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 194633 | 13 |
View Market Depth
| Last trade - 13.04pm 31/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |